QQ客服 官方微博 反馈留言

	Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer
	Yan, Yuqian[1]; An, Jian[2]; Yang, Yinhui[3]; Wu, Di[4]; Bai, Yang[5]; Cao, William[6]; Ma, Linlin[7]; Chen, Junhui[8]; Yu, Zhendong[9]; He, Yundong[10]
刊名	EMBO MOLECULAR MEDICINE
	2018
卷号	10期号:4
关键词	AKT phosphorylation androgen receptor HDAC3 prostate cancer RGFP966
ISSN号	1757-4676
DOI	http://dx.doi.org/10.15252/emmm.201708478
URL标识	查看原文
收录类别	SCI(E)
WOS记录号	WOS:000429322500006
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5337738
专题	江苏大学
作者单位	1.[1]Nanchang Univ, Affiliated Hosp 1, Jiangxi Inst Gastroenterol & Hepatol, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China. 2.Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA. 3.[2]Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA. 4.Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA. 5.[3]Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA. 6.Harbin Med Univ, Hosp 4, Dept Urol, Harbin, Heilongjiang, Peoples R China. 7.[4]Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA. 8.[5]Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA. 9.Harbin Med Univ, Hosp 4, Dept Urol, Harbin, Heilongjiang, Peoples R China. 10.[6]Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA.
推荐引用方式 GB/T 7714	Yan, Yuqian[1],An, Jian[2],Yang, Yinhui[3],et al. Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer[J]. EMBO MOLECULAR MEDICINE,2018,10(4).
APA	Yan, Yuqian[1].,An, Jian[2].,Yang, Yinhui[3].,Wu, Di[4].,Bai, Yang[5].,...&Huang, Haojie[25].(2018).Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.EMBO MOLECULAR MEDICINE,10(4).
MLA	Yan, Yuqian[1],et al."Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer".EMBO MOLECULAR MEDICINE 10.4(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。